← Leaderboards
Ignacio Garrido-Laguna
University Of Utah
$3,846,099
Attributed
$11,280,651
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,280,651 · 2
By mechanism
UM1$10,765,359 · 1
R21$515,292 · 1
Top collaborators
- Susanne M Arnold6 shared
- William E. Carson6 shared
- Dan J Kadrmas2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Donald K Roper$572,575
- Heloisa Prado Soares$1,026,229
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationResponseCancer CellEvaluationClinical TrialsTumorCancer PatientOncologyTissuesDesignBloodReportingSamplingMalignant NeoplasmsSiteFutureCancer Therapy Evaluation ProgramEnrollmentLeadBiopsyClinical Trials NetworkBiomedical ResearchAdvanced Malignant NeoplasmEarly Therapeutic-Clinical Trials Network
Grant awards (8)
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network$1,731,705
UM1 · FY2025 · CA
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network$1,607,030
UM1 · FY2024 · CA
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network$1,722,607
UM1 · FY2023 · CA
Evaluation of deoxynucleosides as a novel resistance mechanism for radiotherapy$124,999
UM1 · FY2021 · CA
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network$100,000
UM1 · FY2021 · CA
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network$5,479,018
UM1 · FY2020 · CA
Multi-Tracer PET/CT Imaging of Gemcitabine Response in Pancreatic Cancer$309,175
R21 · FY2015 · CA
Multi-Tracer PET/CT Imaging of Gemcitabine Response in Pancreatic Cancer$206,117
R21 · FY2014 · CA